Mallinckrodt Pharmaceuticals
MNK
HK$2.67
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Mallinckrodt Pharmaceuticals (MNK) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : HK$35.17 Billion
According to Mallinckrodt Pharmaceuticals 's latest financial reports the company's total liabilities are HK$35.17 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Mallinckrodt Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | HK$34.37 B | -48.75% |
| 2021-12-31 | HK$67.08 B | -0.49% |
| 2020-12-31 | HK$67.41 B | 3.07% |
| 2019-12-31 | HK$65.40 B | 4.53% |
| 2018-12-31 | HK$62.56 B | -8.57% |
| 2017-12-31 | HK$68.43 B | |
| 2016-09-30 | HK$79.32 B | -7.72% |
| 2015-09-30 | HK$85.96 B | 40.03% |
| 2014-09-30 | HK$61.39 B | 244.02% |
| 2013-09-30 | HK$17.84 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | HK$907.15 B | 2,478.65% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | HK$252.34 B | 617.30% | 🇮🇱 Israel |
 General Electric GE | HK$821.53 B | 2,235.27% | 🇺🇸 USA |